Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transcutaneous Lisuride Therapy of Parkinson's Disease
NCT00089622Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Lisuride Patch with Placebo Patch (2 arms). Primary endpoint: Change in parkinsonian severity variance. Started Aug 2004; status: completed.
02
Drugs
lisuride
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00089622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089622.